January is National Substance Use Disorder Treatment month, a time to raise awareness about effective treatments, and reduce ...
Recreational substance use neuroimaging shows diverse cerebrovascular, toxic metabolic, and infectious findings, underscoring ...
A new study provides more evidence that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) used to treat diabetes and obesity could be repurposed for opioid use disorder (OUD) and alcohol use ...
A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in people with opioid and alcohol use disorders. New popular weight-loss and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback